文献速递复苏、休克与脓毒症呼吸衰竭与机械通气

院前高级气道管理成功与失败对院外心脏骤停患者结局的比较

Comparison of outcomes between successful and failed prehospital advanced airway management by paramedic staff in patients with out-of-hospital cardiac arrest.
PubMed 文献 · Eur J Emerg Med · 2025-04-01
一句话结论院前高级气道管理失败与院外心脏骤停患者30天生存率更低、ROSC更低及EMS到达至入院时间更长相关。

这项日本回顾性多中心注册研究分析了2019至2021年间4474例接受院前高级气道管理的院外心脏骤停患者,其中成功组4074例、失败组400例。失败组30天生存率(2.3% vs 4.4%,P=0.043)和ROSC(16.8% vs 29.9%,P<0.001)均低于成功组,EMS到达至入院时间更长(29.0 vs 28.0分钟,P<0.001)。出院生存率(2.0% vs 3.6%,P=0.093)和良好神经功能结局(1.3% vs 1.3%,P=0.930)两组无显著差异。倾向评分匹配后结果趋势相似。作者认为院前高级气道管理失败可能恶化OHCA患者结局。

要点

  • 院前高级气道管理失败组30天生存率2.3%,低于成功组4.4%(P=0.043)。
  • 失败组ROSC率16.8%,低于成功组29.9%(P<0.001)。
  • 失败组EMS到达至入院中位时间29.0分钟,长于成功组28.0分钟(P<0.001)。
  • 出院生存率(2.0% vs 3.6%,P=0.093)和良好神经功能结局(1.3% vs 1.3%,P=0.930)两组无显著差异。
  • 倾向评分匹配后结果趋势相似,作者认为院前高级气道管理失败可能恶化OHCA患者结局。

适用人群与场景

  • 2019至2021年日本回顾性多中心研究中接受院前高级气道管理的院外心脏骤停患者。

研究设计与关键结果

  • 回顾性多中心注册研究,纳入4474例接受院前高级气道管理的OHCA患者,成功组4074例、失败组400例。
  • 主要终点30天生存率:失败组2.3% vs 成功组4.4%(P=0.043),失败组更低。
  • 次要终点ROSC:失败组16.8% vs 成功组29.9%(P<0.001),失败组更低。
  • 出院生存率:失败组2.0% vs 成功组3.6%(P=0.093),无显著差异。
  • 良好神经功能结局:失败组1.3% vs 成功组1.3%(P=0.930),无显著差异。
  • EMS到达至入院中位时间:失败组29.0分钟(25.9-35.0)vs 成功组28.0分钟(22.0-34.0),失败组长于成功组(P<0.001)。
  • 倾向评分匹配后结果趋势相似。

证据类型、等级与局限

  • 证据类型:回顾性多中心注册研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为院前高级气道管理失败可能恶化OHCA患者结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND IMPORTANCE: Although advanced airway management is beneficial for patients with out-of-hospital cardiac arrest (OHCA) in certain situations, the impact of advanced airway management success or failure by the emergency medical service (EMS) crew on the clinical time course and outcomes has not yet been thoroughly evaluated.

OBJECTIVES: To evaluate the impact of EMS crew members' prehospital advanced airway management failure on patient outcomes in OHCA.

DESIGN: Retrospective multicentre registry study.

SETTING AND PARTICIPANTS: Data from an OHCA survey in a Japanese retrospective multicentre study conducted between 2019 and 2021 were reviewed.

OUTCOME MEASURES AND ANALYSIS: Patients who underwent advanced airway management were divided into success and failure groups. The baseline characteristics and outcomes of the two groups were evaluated. Propensity score matching was performed by creating matched success and failure groups to analyse sensitivity. The primary outcome was 30-day survival, and secondary outcomes were favourable neurological outcomes at discharge, time from on-scene EMS arrival to hospital arrival, and return of spontaneous circulation (ROSC).

MAIN RESULTS: Overall, 4474 patients who underwent prehospital advanced airway management were analysed. Among them, 4074 and 400 patients were in the success and failure groups, respectively. The 30-day survival rates (success vs. failure, 4.4 vs. 2.3%; P = 0.043) and ROSC (29.9 vs. 16.8%; P < 0.001) in the failure group were lower than those in the success group. There were no significant differences in survival rate at hospital discharge (3.6 vs. 2.0%; P = 0.093) and favourable neurological outcomes (1.3 vs. 1.3%; P = 0.930) between the groups. The median time from on-scene EMS arrival to hospital arrival (min) [28.0 (22.0-34.0) vs. 29.0 (25.9-35.0); P < 0.001] in the failure group was longer than that in the success group. After propensity score matching, the results showed a similar trend.

CONCLUSION: Prehospital advanced airway management failure was associated with lower 30-day survival rates, ROSC, and a longer time between EMS arrival and hospital arrival. These findings suggest that failure of prehospital advanced airway management could potentially worsen the outcomes of patients with OHCA.

来源:Eur J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Takayama W, Sugimoto M, Morishita K, et al. Comparison of outcomes between successful and failed prehospital advanced airway management by paramedic staff in patients with out-of-hospital cardiac arrest. Eur J Emerg Med. 2025. PMID: 40170595. doi:10.1097/MEJ.0000000000001231

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。